Where are we with MRD assessment in CLL management?
27 April 2021 - 44 Minutes

Where are we with MRD assessment in CLL management?

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Paolo Ghia and Dr Andrew Rawstron will discuss minimal residual disease (MRD) assessment in CLL with particular focus on:

•    How to measure MRD and the interpretation of results
•    The impact that MRD assessment could have on the clinical management of ...

more info...

EM-49349
Consideration for difficult to treat relapses
14 April 2021 - 49 Minutes

Consideration for difficult to treat relapses

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss the potential treatment options for managing patients with multiple myeloma after multiple relapses 

 

Moderator:

  • Michel Delforge (Belgium)

 

Faculty:

  • María Victoria Mateos (Spain)
more info...

EM-55450
Using genomics to guide clinical management in CLL
13 April 2021 - 45 Minutes

Using genomics to guide clinical management in CLL

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Kostas Stamatopoulos and Professor Gianluca Gaidano will discuss why and how the clinical management of patients with CLL should be guided by both disease- and patient-specific characteristics.

During the live broadcast you will have the opportunity to ask questions and interact ...

more info...

EM-49347
Minimal Residual Disease - the end of the rainbow?
8 April 2021 - 44 Minutes

Minimal Residual Disease - the end of the rainbow?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the role of minimal residual disease in the management of patients with multiple myeloma    

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • Jesús San Miguel (Spain)
more info...

EM-48509
ON DEMAND webinar: A look into the future: how will cellular therapies affect our clinical practice in multiple myeloma?
30 March 2021 - 60 Minutes

ON DEMAND webinar: A look into the future: how will cellular therapies affect our clinical practice in multiple myeloma?

Video recording by the congress organisers of the Janssen Symposium from the 47th Annual Meeting of the EBMT that took place on 16 March 2021.

 

Learning objective:

After attending this symposium delegates should be able to:

  • Describe the current cellular therapy approaches for patients with multiple myeloma
  • Discuss the latest evidence supporting the use of cellular ...
more info...

EM-55017
ON DEMAND webinar: Is the gold standard for managing transplant eligible newly-diagnosed multiple myeloma still golden?
28 March 2021 - 91 Minutes

ON DEMAND webinar: Is the gold standard for managing transplant eligible newly-diagnosed multiple myeloma still golden?

Video recording by the congress organisers of the Janssen Symposium from the 47th Annual Meeting of the EBMT that took place on 14 March 2021.

 

Learning objective:

After attending this symposium delegates should be able to:

  • Explain the impact of latest data on the role of transplantation in the frontline management of patients with multiple myeloma
  • ...
more info...

EM-55016
Challenging cases in Waldenström’s macroglobulinemia
23 March 2021 - 49 Minutes

Challenging cases in Waldenström’s macroglobulinemia

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Christian Buske and Dr Ramon Garcia-Sanz will discuss challenging cases in Waldenström’s macroglobulinemia with particular focus on:

•    Selecting 1st line treatment
•    Treatment options in the relapsed setting
•    Role of transplantation

During the live broadcast you will have the opportunity to ask ...

more info...

EM-49346
ON DEMAND Webinar: Managing patients with MM, now and in the new normal
13 March 2021 - 64 Minutes

ON DEMAND Webinar: Managing patients with MM, now and in the new normal

Video recording by the congress organisers of the Janssen Symposium from the 2nd EMN Meeting that took place on 4 March 2021.

 

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss treatment approaches for patients at different stages of their multiple myeloma
  • Explain how data updates may impact the management of patients with multiple ...
more info...

EM-55010
High risk myeloma - what does it mean and how to treat it?
11 March 2021 - 51 Minutes

High risk myeloma - what does it mean and how to treat it?

Learning objective:

After participating in this broadcast you should be able to:

  • Explain the definition of high-risk multiple myeloma and treatment options for patients  

 

Moderator:

  • Mohamad Mohty (France)

 

Faculty:

  • María Victoria Mateos (Spain)
more info...

EM-48508
The key things you need to know about managing cardiac morbidities in patients with CLL
9 March 2021 - 52 Minutes

The key things you need to know about managing cardiac morbidities in patients with CLL

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor John Gribben and Professor Alex Lyon will discuss the management of cardiac morbidities in patients with CLL, with a particular focus on:

•    Pre-treatment patient assessment
•    Treatment selection and patient monitoring
•    Optimal management of treatment-related adverse events

During the live broadcast you will ...

more info...

EM-49345
;